Lactobacillus plantarum TRB14 and its application in fermentation and conversion of ginsenoside Rb1 to prepare rare ginsenosides

By fermenting and converting ginsenoside Rb1 with Lactobacillus plantarum TRB14, rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5 are generated, which solves the problem of insufficient conversion of rare ginsenosides in the existing technology, realizes the preparation of rare ginsenosides with high efficiency and low cost, and improves the quality of drugs and health products.

CN117625477BActive Publication Date: 2024-11-29JILIN ACAD OF AGRI SCI
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202311619388.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-11-30
Publication Date
2024-11-29
Estimated Expiration
2043-11-30

AI Technical Summary

Technical Problem

In existing technologies, lactic acid bacteria fermentation technology is rarely used to convert rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5, and it is difficult to effectively improve the content and pharmacological activity of rare ginsenosides in ginseng extracts.

Method used

Ginsenoside Rb1 was fermented and transformed using Lactiplantibacillus plantarum TRB14. After hydrolysis of glucose at the C-20 position, rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5 were generated.

Benefits of technology

This study has achieved efficient preparation of rare ginsenosides with mild reaction and low cost. The resulting rare ginsenosides have broad application prospects and improve the quality and efficacy of drugs and health products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117625477B_ABST
    Figure CN117625477B_ABST
Patent Text Reader

Abstract

Lactobacillus plantarum TRB14 and its application in fermenting and transforming ginsenoside Rb1 to prepare rare ginsenosides relate to the field of probiotic fermentation. Lactobacillus plantarum TRB14 was deposited in the China Center for Type Culture Collection on October 23, 2023, with a deposit number of CCTCC NO: M20231992. The present invention uses ginsenoside Rb1 as a raw material, and utilizes Lactobacillus plantarum TRB14 to perform biological fermentation transformation on ginsenoside Rb1 to obtain high-content rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5, which has the advantages of mild reaction, low cost and safe process, and provides a new way for the preparation of rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of probiotic fermentation, and in particular to a Lactobacillus plantarum TRB14 and an application thereof in fermenting and transforming ginsenoside Rb1 to prepare rare ginsenosides. Background Art

[0002] Ginseng (Panax ginseng) is widely regarded as a precious Chinese herbal medicine with a variety of pharmacologically active ingredients, the most important of which are ginsenosides. Ginsenosides are believed to have a variety of medicinal and health effects, such as anti-fatigue, improving cognitive function, enhancing immunity and anti-oxidation. However, different types of ginsenosides differ in their efficacy, and some of them have powerful pharmacological activities and are called rare ginsenosides.

[0003] Lactic acid bacteria are a type of probiotic bacteria that have been widely used in food fermentation, probiotic preparation, and drug production. In recent years, the fermentation technology of lactic acid bacteria has aroused interest in its application in the extraction and improvement of active ingredients from herbal plants. The application of lactic acid bacteria in the transformation and extraction of ginsenosides is a novel method aimed at increasing the content of rare ginsenosides in ginseng extracts, thereby improving their pharmacological activity and efficacy. Lactic acid bacteria fermentation technology provides a new method for improving the efficacy and quality of herbal medicines. Through this technology, ginsenosides, especially rare ginsenosides, can be transformed, bringing new opportunities for the preparation of drugs and health products. This not only improves the quality of traditional Chinese medicine preparations, but also reduces production costs, while also bringing more innovations to the fields of medicine and health care. Future research and practice will further explore the application of lactic acid bacteria fermentation technology in the extraction and improvement of active ingredients, providing possibilities for the research and development of herbal medicines. At present, there are not many reports on the transformation of rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1, and Rg5 using lactic acid bacteria. Summary of the invention

[0004] In order to solve the problems existing in the prior art, the present invention provides a Lactobacillus plantarum TRB14 (Lactiplantibacillus plantarum) and its application in fermenting and transforming ginsenoside Rb1 to prepare rare ginsenosides. The present invention uses ginsenoside Rb1 as a substrate and utilizes the extracted Lactobacillus plantarum TRB14 to perform fermentation and transformation to prepare rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5.

[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0006] The Lactobacillus plantarum TRB14 provided by the present invention has been deposited in the China Center for Type Culture Collection on October 23, 2023, with the deposit number: CCTCC NO: M20231992.

[0007] The invention provides an application of Lactiplantibacillus plantarum TRB14 in fermenting and transforming ginsenoside Rb1 to prepare rare ginsenosides.

[0008] As a preferred embodiment, the rare ginsenosides include 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5.

[0009] As a preferred embodiment, the biotransformation synthesis route of the rare ginsenosides is: the ginsenoside Rb1 is hydrolyzed by Lactiplantibacillus plantarum TRB14 to form the rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5 after the glucose at the C-20 position of the ginsenoside Rb1 is dehydrated.

[0010] As a preferred embodiment, the use of Lactiplantibacillus plantarum TRB14 in the fermentation and conversion of ginsenoside Rb1 to prepare rare ginsenosides provided by the present invention mainly comprises the following steps:

[0011] Step 1: preparing a Lactobacillus plantarum TRB14 bacterial suspension;

[0012] Lactobacillus plantarum TRB14 was inoculated into liquid MRS medium and cultured at 37-45°C for 16-25h. The culture was centrifuged at 4000-8000 rpm for 5-10min at 4-10°C. The bacterial precipitate was collected and suspended with a fermentation sterilization medium aqueous solution to adjust the viable bacterial count to 1.0×10 9 ~1.0×10 10 CFU / ml, obtain the plant lactobacillus (Lactiplantibacillus plantarum) TRB14 bacterial suspension;

[0013] Step 2: Fermentation conversion;

[0014] A liquid fermentation medium is prepared, 10-20 g / L of ginsenoside Rb1 is added thereto, and a Lactiplantibacillus plantarum TRB14 bacterial suspension is inoculated at an inoculum amount of 10-30 ml / L, and the culture medium is allowed to stand and ferment at 37-42° C. for 14-28 days; after the fermentation is completed, the obtained fermentation product is subjected to low-temperature reduced pressure concentration and freeze-dried, the product is extracted with methanol, centrifuged, the supernatant is reduced pressure to recover the solvent, and then freeze-dried to obtain a dry product, which contains rare ginsenosides.

[0015] As a preferred embodiment, the liquid fermentation medium comprises: 2-5 g / L glucose and 1-3 g / L yeast extract; pH 6.0-7.0.

[0016] The beneficial effects of the present invention are as follows:

[0017] In order to achieve biotransformation to prepare rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5, the present invention first screened a strain TRB14 from the traditional fermented pickled cucumber samples and identified it. The result showed that it was Lactiplantibacillus plantarum and was preserved in the China Center for Type Culture Collection on October 23, 2023, with the preservation number: CCTCC NO: M20231992. Then, ginsenoside Rb1 was used as raw material and the rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5 were obtained by bio-fermentation transformation of ginsenoside Rb1 using Lactiplantibacillus plantarum TRB14. At the same time, the transformed rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5 were identified by HPLC chromatography. The results showed that the retention time of the conversion product of ginsenoside Rb1 was consistent with that of the rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5 standards. Therefore, the use of Lactiplantibacillus plantarum TRB14 of the present invention to ferment and transform ginsenoside Rb1 can obtain high-content rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5, which has the advantages of mild reaction, low cost and safe process, and the prepared rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5 are widely used and have broad application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1HPLC chromatograms of ginsenoside Rb1 on days 0, 7, 14, 21, and 28 of fermentation.

[0019] Figure 2 It is a biotransformation synthesis route for rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1, and Rg5. DETAILED DESCRIPTION

[0020] The plant lactobacillus (Lactiplantibacillus plantarum) TRB14 provided by the present invention has been deposited in the China Center for Type Culture Collection on October 23, 2023, with the deposit number: CCTCC NO: M20231992.

[0021] The present invention provides an application of Lactiplantibacillus plantarum TRB14 in fermenting and transforming ginsenoside Rb1 to prepare rare ginsenosides, which mainly comprises the following steps:

[0022] Step 1: preparing a Lactobacillus plantarum TRB14 bacterial suspension;

[0023] Lactobacillus plantarum TRB14 was inoculated into liquid MRS medium and cultured at 37-45°C for 16-25h. The culture was centrifuged at 4000-8000 rpm for 5-10min at 4-10°C. The bacterial precipitate was collected and suspended with a fermentation sterilization medium aqueous solution to adjust the viable bacterial count to 1.0×10 9 ~1.0×10 10 CFU / ml, obtain the plant lactobacillus (Lactiplantibacillus plantarum) TRB14 bacterial suspension;

[0024] Step 2: Fermentation conversion;

[0025] The method comprises the following steps: preparing a liquid fermentation medium, wherein the liquid fermentation medium comprises 2-5 g / L of glucose and 1-3 g / L of yeast extract powder; and the pH value is 6.0-7.0; adding 10-20 g / L of ginsenoside Rb1 to the liquid fermentation medium, and inoculating a Lactobacillus plantarum TRB14 bacterial suspension at an inoculum amount of 10-30 ml / L, and fermenting the culture medium at 37-42 DEG C for 14-28 days; after the fermentation is completed, performing low-temperature reduced-pressure concentration and freeze-drying on the obtained fermentation product, extracting the product with methanol, centrifuging, recovering the solvent from the supernatant under reduced pressure, and then freeze-drying the product to obtain a dry product, wherein the dry product contains rare ginsenoside.

[0026] Among them, rare ginsenosides mainly include 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5.

[0027] Among them, the biotransformation synthesis route of rare ginsenosides is: the ginsenoside Rb1 is hydrolyzed by Lactiplantibacillus plantarum TRB14 to form rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5 after the glucose at the C-20 position of ginsenoside Rb1 is dehydrated.

[0028] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0029] Example 1 Isolation, identification and preservation of strains

[0030] 1. Isolation of strains

[0031] The samples used for the isolated strains were traditionally fermented pickled cucumber samples collected from Yanji City, Jilin Province in September 2018. The traditionally fermented pickled cucumber samples collected were ground, and then diluted step by step with sterile saline in multiples of 10 to obtain dilutions; the dilutions at each level were respectively applied to the acid-producing bacteria isolation medium plate added with bromocresol purple, and cultured at 37°C for 48h; when a single colony appeared on the acid-producing bacteria isolation medium plate, half of the colonies that could cause bromocresol purple to change color were selected for microscopic examination according to the morphology of the single colony, and the other half of the colonies were inoculated into MRS solid culture medium for continued culture, and G(+) colonies were further selected. This was repeated 3 times, and pure culture was obtained by separation and purification; the obtained pure culture strains were inoculated into liquid MRS culture medium for continued culture, and after adding 60% glycerol, they were stored in a -80°C refrigerator. One of the lactobacilli was named TRB14.

[0032] 2. Identification of strains

[0033] (1) Physiological and biochemical identification results of strain TRB14: Gram staining positive, catalase test negative, benzidine test negative, indole test negative, acetylmethyl carbinol test positive; does not hydrolyze starch, does not liquefy gelatin, does not produce hydrogen sulfide, ferments glucose to produce acid but not gas; is a non-motile bacillus; can grow at 15°C and 45°C, with the optimum growth temperature being 37-42°C; has a suitable pH of 5.0-7.0; tolerates 6.5% NaCl; grows uniformly turbid in liquid MRS medium, and the bacteria form white precipitates after long-term storage.

[0034] (2) 16S rDNA sequence homology analysis: The genomic DNA of strain TRB14 was extracted and PCR amplification was performed using a primer pair consisting of 16sF and 16sR (16sF: 5'-AGAGTTTGATCCTGGCTCAG-3'; 16sR: 5'-AGAAAGGAGGTGATCCAGC-3'). The PCR amplification conditions were as follows: pre-deformation: 95℃ for 5 min; denaturation: 95℃ for 15 s, annealing: 55℃ for 15 s, extension: 72℃ for 1.5 min, for a total of 35 cycles; final extension: 72℃ for 7 min, and storage at 4℃. Then the amplified product was sequenced, and the 16s rDNA sequence was shown in SEQ ID NO: 1; the 16s rDNA sequence was compared and analyzed in the GenBank library by the BLAST program, and it was found that the homology between strain TRB14 and Lactiplantibacillus plantarum strain MSJK0068 (GenBank: CP136674.1) reached 99.7%. Based on the above results, strain TRB14 was identified as Lactiplantibacillus plantarum.

[0035] Wherein, the primer pair sequence information is as follows:

[0036] 16sF: 5′-AGAGTTTGATCCTGGCTCAG-3′;

[0037] 16sR: 5′-AGAAAGGAGGTGATCCAGC-3′.

[0038] 3. Preservation of strains

[0039] The plant lactobacillus (Lactiplantibacillus plantarum) TRB14 of the present invention has been deposited in the China Center for Type Culture Collection, abbreviated as CCTCC, on October 23, 2023. The address is: Wuhan University, No. 299, Bayi Road, Wuchang District, Wuhan City, Hubei Province (Wuhan University Collection Center), and the preservation number is: CCTCC NO: M20231992.

[0040] Example 2 Preparation of rare ginsenosides by fermentation of ginsenoside Rb1 with Lactiplantibacillus plantarum TRB14

[0041] 1. Preparation of Lactiplantibacillus plantarum TRB14 bacterial suspension

[0042] Lactiplantibacillus plantarum TRB14 was inoculated into liquid MRS medium and cultured at 37°C for 16 h. The culture was centrifuged at 4°C and 6000 rpm for 8 min, and the bacterial precipitate was collected. The culture was suspended with a fermentation sterilized medium aqueous solution and the number of viable cells was adjusted to 1.0×10 9 CFU / mL, and obtain the plant lactobacillus (Lactiplantibacillus plantarum) TRB14 bacterial suspension.

[0043] 2. Prepare ginsenoside Rb1

[0044] The commercially available ginsenoside Rb1 was purchased from Shanghai Yuanye Biotechnology Co., Ltd., and its purity was greater than 98%.

[0045] 3. Fermentation conversion

[0046] A liquid fermentation medium is prepared, the liquid fermentation medium includes 3g / L glucose and 1g / L yeast extract powder, pH 6.6, and is sterilized at 121°C for 15min. In the liquid fermentation medium, the amount of ginsenoside Rb1 added is 10g / L, and a Lactiplantibacillus plantarum TRB14 bacterial suspension is inoculated at an inoculum volume of 10ml / L, and the fermentation is allowed to stand at 37°C for 21 days. After the fermentation is completed, the obtained fermentation product is subjected to low-temperature (50°C) reduced pressure concentration and vacuum freeze drying (-80°C, 5pa), and the product is extracted with methanol, centrifuged (10000rpm, 15min, 4°C), and the supernatant is vacuum-freeze dried (-80°C, 5pa) after the solvent is recovered under reduced pressure to obtain a dry product, which contains rare ginsenosides.

[0047] Example 3 Identification of rare ginsenosides

[0048] High performance liquid chromatography (HPLC) was used to detect the rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5: ginsenoside Rb1 and the dried product obtained above were dissolved in methanol, filtered through a 0.22 μm microporous filter membrane and used for HPLC chromatographic analysis.

[0049] The HPLC chromatographic analysis method was as follows: chromatographic column Agilent pursuit5 SB-C18 column, injection volume 20 μL, flow rate 1 mL / min, column temperature 30°C, detection wavelength 203 nm. The mobile phase was A: water, B: acetonitrile, 0-40min 18-21% (B); 40-42min 21-26% (B); 42-46min 26-32% (B); 46-66min 32-34% (B); 66-71min 34-38% (B); 71-77.70min 38.0-49.1% (B); 77.70-82min 49.1% (B); 82-83min 49.1-50.6% (B); 83-88min 50.6-59.6% (B); 88-89.80min 59.6-65.0% (B); 89.80-97min 65% (B); 97-102min 65~75%(B); 102~110min 75~85%(B); 110~115min 85%(B); 115~125min 85~18%(B); 125~130min 18.0%(B).

[0050] HPLC chromatographic identification results are as follows Figure 1 As shown in the figure, through the qualitative and quantitative analysis of the ginsenoside components in the products before and after fermentation, it can be seen that the retention time of the conversion product of ginsenoside Rb1 is consistent with that of the rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5 standards. This proves that ginsenoside Rb1 can be converted into rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5 by Lactiplantibacillus plantarum TRB14 fermentation. In addition, as Figure 2 As shown, the biotransformation synthesis route for preparing rare ginsenosides using Lactiplantibacillus plantarum TRB14 fermentation transformation is as follows: ginsenoside Rb1 is hydrolyzed by Lactiplantibacillus plantarum TRB14 at the C-20 position of ginsenoside Rb1 and then dehydrated to generate rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5.

[0051] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

[0052]

[0053]

Claims

1. Lactobacillus plantarum TRB14, characterized in that It was deposited in the China Center for Type Culture Collection on October 23, 2023, with the deposit number: CCTCCNO: M20231992.

2. The use of Lactiplantibacillus plantarum TRB14 as claimed in claim 1 in fermenting and converting ginsenoside Rb1 to prepare rare ginsenosides, characterized in that: The rare ginsenosides are 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5.

3. The use according to claim 2, characterized in that: The biological transformation synthesis route of the rare ginsenosides is as follows: the ginsenoside Rb1 is hydrolyzed by Lactiplantibacillus plantarum TRB14 to form the rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5 after the glucose at the C-20 position of the ginsenoside Rb1 is dehydrated.

4. The use according to claim 2, characterized in that: The following steps are involved: Step 1: preparing a Lactobacillus plantarum TRB14 bacterial suspension; Lactobacillus plantarum TRB14 was inoculated into liquid MRS medium and cultured at 37-45°C for 16-25h. The culture was centrifuged at 4000-8000 rpm for 5-10min at 4-10°C. The bacterial precipitate was collected and suspended with a fermentation sterilization medium aqueous solution to adjust the viable bacterial count to 1.0×10 9 ~1.0×10 10 CFU / ml, obtain the plant lactobacillus (Lactiplantibacillus plantarum) TRB14 bacterial suspension; Step 2: Fermentation conversion; A liquid fermentation medium is prepared, 10-20 g / L of ginsenoside Rb1 is added thereto, and a Lactobacillus plantarum TRB14 bacterial suspension is inoculated at an inoculum amount of 10-30 ml / L, and the culture medium is allowed to stand and ferment at 37-42° C. for 14-28 days. After the fermentation is completed, the obtained fermentation product is subjected to low-temperature reduced pressure concentration and freeze-dried, the product is extracted with methanol, centrifuged, the supernatant is subjected to reduced pressure to recover the solvent, and then freeze-dried to obtain a dry product containing rare ginsenosides 20(R)-Rg3, 20(S)-Rg3, Rk1 and Rg5.

Citation Information

Patent Citations

  • Ginseng fermentation liquor fermented by lactic acid bacteria as well as preparation method and application of ginseng fermentation liquor

    CN116831284A

  • Microorganisms for fermentation of red ginseng and food composition containing fermented red ginseng

    KR100866504B1

  • Black ginseng lactic acid bacteria fermentation composition and method for producing the same

    KR102053735B1

  • KR20200145254A